ATXN7L2 is a paralog of the ataxin-7 gene located on chromosome 1. While its primary function remains incompletely characterized, emerging evidence suggests roles in circadian rhythm regulation and metabolic control. In genetic studies of chr1 and sleep preferences, the rs12044778 variant in the GPR61 locus was associated with increased ATXN7L2 expression specifically in the cerebellum 1. Functional knockout studies demonstrated that ATXN7L2 deletion reduced body weight without affecting activity levels, suggesting a role in metabolic regulation 1. ATXN7L2 is also implicated in lung cancer prognosis, where variants correlated with ATXN7L2 expression were identified through expression quantitative trait loci (eQTL) analysis and showed significant differential expression between tumor and normal lung tissue in non-small cell lung cancer patients 2. As a paralog of disease-associated ATXN7, which causes spinocerebellar ataxia 7, ATXN7L2 represents a potential candidate gene for understanding polyglutamine ataxia neuropathology, though this remains speculative without direct evidence of functional redundancy 3. Current evidence suggests ATXN7L2 participates in tissue-specific regulation of circadian and metabolic phenotypes, though its precise molecular mechanisms warrant further investigation.